GSK (LSE:GSK) Poised for Growth with Strong Sales, Strategic Alliances, and New Vaccine Launches
GSK(LSE:GSK) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a ...
Analyst Issues Sell Rating for GlaxoSmithKline Amid Market Share and Litigation Concerns
Analyst Graham Parry of Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), retaining the ...
FiercePharma4d
GSK makes Brooke Shields the star of shingles vaccination push
GSK has turned to Brooke Shields to get the message out about shingles vaccination. | GSK has turned to Brooke Shields to get ...
BioSpace2d
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...
GSK says mRNA flu shot shows promise in boost for pipeline
GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage trial.
The Pharma Letter2d
Good signs for co administration of GSK’s RSV and shingles vaccines
UK drugmaker GSK presented positive Phase III trial data at the European Geriatric Medicine Society Congress. The trial ...
Alume Biosciences Appoints Rick Gonzalez as Chief Commercial Officer
Alume Biosciences is pleased to announce the appointment of Rick Gonzalez as Chief Commercial Officer. With over three ...
Seeking Alpha26d
GSK's Q2 Success Amid Challenges: What Investors Need To Know
So, what are the reasons for the commercial success of GSK's future blockbuster? The answer is quite simple and lies in the fact that there remains an extremely high demand for it both as a ...
The Pharma Letter11d
GSK reports positive Phase III results for depemokimab
GSK (LSE: GSK) announced full results from its SWIFT-1 and SWIFT-2 Phase III trials for depemokimab, an ultra-long-acting ...